Yatiri Bio Inc

Yatiri Bio was created to address the inefficiencies of cancer drug discovery and development, focusing on the translational gap between discovery and clinical success. The inherent heterogeneity in cancer patients requires both a new methodology and a systemwide approach. Past experience and data have shown that simple models often lead to expensive failures. We can do better. At Yatiri Bio we use unbiased proteomics, deep learning and patient derived cellular systems to create a molecularly defined patient landscape with empirically testable cellular systems embedded within it to identify the ideal patient subsets for novel therapeutics